Offering statins to a population attending health checks with a 10-year cardiovascular disease risk between 10% and 20.

The proportion choosing to start a statin was substantially lower than previously estimated. Large population-based studies with long-term follow-up are needed to assess the impact on health and workload of this change in guidance.